한국 정보
 
 
DISTRIBUTORS: Ask
about opportunities
to
offer MYELOTEC
products to your
customers.
 

Over the past ten years Myelotec has developed, patented and successfully commercialized its steerable catheter and endoscope technology. Myelotec endoscopic technology enables physicians to diagnose and deliver a drug onto an inflamed nerve root with precision, resulting in less damage to surrounding tissues and minimal impact on the patient’s musculoskeletal
structure.

 

Back pain is the number one medical complaint in the United States today. More than half of all Americans will suffer from back pain during some period of their life, and we currently spend more than $20 billion annually on disability claims, therapy, non-surgical devices and supports, and surgery to treat the pain. 

The Myelotec line of interventional pain management devices can relieve debilitating pain with
precision, resulting in
less damage to
surrounding tissues
and minimal impact
on the patient’s
musculoskeletal
structure.

 

The number of degenerative disc procedures in the U.S. and internationally is expected to increase from 1 million in 2005 to 1.7 million in 2008. Myelotec offers a complete line of steerable catheters, fiber optic endoscopes, light guides, and supporting devices which permit physicians to treat back pain with precision, resulting in less damage to surrounding tissues and minimal impact on the patient’s musculoskeletal structure.